Hyris and Singlabs signed a distributorship agreement for Singapore
Hyris and Signlabs will partner together to commercialize Hyris signature technology, Hyris System™, and Hyris testing solutions in Singapore.
Related links:
-
Hyris signs a distribution agreement with GrowBIGogh
-
Hyris technology supports the fight against one of the world’s deadliest diseases, malaria.
-
Hyris fulfils its integration into Ulisse Biomed to give birth to a new international group ready to make its mark in the global biotech market.
-
Distribution agreement renewal with Biomol Laboratories, fostering the partnership in the field of personalised medicine
-
Hyris' signed a binding agreement for a reverse take-over, leading to a new integrated entity with Ulisse Biomed
-
Hyris' new onboarding programs support researchers and developers to launch testing kits.
-
Hyris Founder&CEO Stefano Lo Priore interviewed by Carter&Benson
-
Hyris and Singlabs signed a distributorship agreement for Singapore
-
Hyris and P.Intertrade Equipments signed a distributorship agreement for Thai market.
-
Hyris to participate to SIBioC 2022 in Genova, presenting Hyris marketplace approach for laboratory medicine